AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform. “With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll […]
Blog
Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech. Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo, […]
Moderna’s new CFO leaves after former employer discloses investigation
Moderna (Nasdaq:MRNA) CFO Jorge Gomez is gone from his new job effective immediately, the COVID-19 vaccine maker said today. Cambridge, Massachusetts–based Moderna said the departure comes after Gomez’s former employer, Dentsply Sirona (Nasdaq: XRAY), announced an “ongoing internal investigation into certain matters, including financial reporting,” Moderna said in a news release. Get the full story […]
Globus Medical misses with Q1 results
Globus Medical (NYSE:GMED) posted first-quarter results today that missed the consensus forecast on Wall Street and reaffirmed its outlook for the rest of the year. The Audubon, Pennsylvania–based musculoskeletal solutions developer today reported profits of $38.1 million, or $0.37 per diluted share, on sales of $230.5 million for the three months ended March 31, 2022, […]
Pfizer to shell out $11.6B for migraine drugmaker Biohaven
Pfizer (NYSE:PFE) today announced that it has entered into an agreement to acquire Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN), which is best known for Nurtec ODT (rimegepant), a dual-acting migraine therapy. Pfizer will pay $148.50 per share in cash to acquire Biohaven, totaling approximately $11.6 billion. Get the full story from our sister site, Pharmaceutical […]
Alcon beats the Street with Q1 results
Alcon (SIX/NYSE:ALC) posted first quarter results today that beat the consensus forecast on Wall Street and maintained its sales and earnings outlook for the rest of the year. The Geneva, Switzerland–based eye care tech company reported profits of $168 million, or $0.34 per share, on sales of $2.2 billion for the three months ended March […]
Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’
A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, vice president of venture capital at Medtronic (NYSE: MDT). He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company (read more in his DeviceTalks speaker bio). Medtronic has more than $500 million in […]
gBETA Medtech accelerator picks its next startups
The gBETA Medtech virtual accelerator today named the five startups that will participate in the spring program leading up to the June 21 showcase day. “We’re so fortunate to have such a diverse set of founders with expertise across the healthcare continuum,” gBETA Medtech Director KC Caine said in a news release. “Our founders are […]
FDA warns of potential toxic risk from Fresenius hemodialysis machines
The FDA is evaluating the risk of exposure to toxic chemicals from silicone tubing used in Fresenius Medical Care (NYSE: FMS) hemodialysis machines. The investigation concerns three models of Fresenius hemodialysis machines: the 2008T, 2008K2, and 2008K. The chemicals — non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) and NDL polychlorinated biphenyls (PCBs) — are in the […]
Thanks, mom! Medtech leaders reflect on Mother’s Day
Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised. As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve built. We […]
iRhythm stock soars on Street-beating Q1; C-Suite changes continue
iRhythm Technologies (Nasdaq:IRTC) posted first-quarter results that beat the consensus forecast on Wall Street and increased its outlook for the rest of the year, sending the stock up more than 10% by this morning. The San Francisco-based developer of remote external electrocardiogram monitors reported a net loss of $50.6 million, or -$1.71 per share, on […]